Essilor’s Stellest Lenses Receive FDA Breakthrough Device Designation
CHARENTON-LE-PONT, France — The U.S. Food and Drug Administration (FDA) granted Essilor’s Stellest lenses the Breakthrough Device designation. With this FDA recognition, and on the heels of Essilor’s two-year clinical trial for the Stellest lenses, Essilor will be able to pursue further testing and research related to myopia management.
Original Article Source Credits: Review of MM, https://reviewofmm.com/
Article Written By: NA
Original Article Posted on: May 17, 2021
Link to Original Article: https://reviewofmm.com/essilors-stellest-lenses-receive-fda-breakthrough-device-designation/